Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for prevention of vancomycin-induced renal disorder
IRCT20150721023282N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetylcysteine in nephrotoxicity (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Serum creatinine, Blood urea nitrogen and 3 more. Started Sep 2017; status: completed.
02
Drugs
acetylcysteine
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on IRCT20150721023282N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150721023282N3.